Isotope Encephalography: Experience with 100 Cases* JAMES W. D. BULL,t M.D., F.R.C.P., F.F.R.; JOHN MARRYAT,t L.R.C.P., M.R.C.S.
[WITH SPECIAL PLATE ] Brit. med.,J., 1965, 1, [474] [475] [476] [477] [478] [479] [480] Isotopes have been used for the detection and location of intracranial lesions since 1948 (Moore, 1948) . In 1947 Moore demonstrated that fluorescein injected intravenously was selectively absorbed by gliomas (astrocytomas) and other tumours. When an ultraviolet light was shone on the exposed brain, a glioma reaching the surface reflected a different colour-yellow -from the remainder of the brain. Moore argued that if sodium diiodofluorescein tagged with 13 I was injected intravenously it should be possible with the aid of a Geiger-Muller counter to detect brain tumours through the intact skull. In this he was successful. Since then a large number of isotopes have been used for this purpose, and the apparatus designed for the detection of the emitted radiation has become more and more sensitive and sophisticated.
Many neurological centres, particularly in the United States, are now using isotopes routinely for establishing the detection of brain tumours. Until recently the method has been applied relatively little in Europe, with the notable exception of the work of Planiol (1963) , of Paris, whose experience spans about a decade. Most Europeans, with the above outstanding exception, have largely relied on the well-established techniques of pneumography and angiography, which for the most part have proved so satisfactory. Furthermore, until lately, visits to centres in the U.S.A. did not suggest that the results warranted the installation of the then very expensive equipment which was necessary to carry out isotope encephalography. However, the work of such men as Di Chiro (1961) , Blau and Bender (1962) , Brinkman et al. (1962) , Pitlyk et al. (1963) , and others has been so striking that further delay in attempting to confirm their results did not seem justified.
Besides this, the economic picture has changed radically in that several commercial firms now market apparatus capable of detecting isotopes. Not only has the price of equipment become much more reasonable, but it has been sufficiently simplified to allow scanning to be easily undertaken in the x-ray department without the aid of a physicist. The work to be described was carried out with a Picker Magnascanner and the isotope used in the first 100 cases (May 1963 to January 1964) was 2"'Hg chlormerodrin (Neo- hydrin). Patients were selected only to the extent that those under the age of 18 years were excluded on the grounds of possible radiation damage to the kidneys. All the cases examined were suspected clinically of harbouring an intracranial mass.
Method
In order to produce a strictly comparable series, the first 100 cases were scanned without any change of technique and under as nearly as possible identical conditions. The patient was prepared 24 hours before receiving the isotope with an intramuscular injection of 1 ml. of meralluride (Mercardan). This mercury compound was given to reduce the uptake of the isotope by the kidneys and thus reduce the renal radiation dose.
Early on the day of the examination the patient received an intravenous injection of 10 nuc/kg. body weight of ""Hg chlormerodrin, with a maximum dose of 700 tc, irrespective of excess weight. Since the optimum interval between injection and scan has been estimated at six hours, the scn (whkh takes two hours) was started five hours after injection. The scanning process is achieved by the passage of a focused detector backward and forward across the patient's head. At the end of each traverse the detector moves up 2 mm. so that it covers the area to be scanned rather in the manner of mowing a lawn. The recording is made by a small light source (2 mm. diameter), mechanically coupled with the detector, which consequently covers an exactly equivalent area. The brightness of the light varies with the strength of the emission from the patient and shines on to an ordinary x-ray film contained in a light-tight compartment within the machine. Thus when the emission is high the light is bright and the film upon which it plays is dark. Conversely, where the emission is low the film is clear. The settings on the machine have to be varied in each case, depending on the maximum and minimum counts. These are determined by a preliminary survey of the skull before the scanning proper begins.
Immobilization of the head is all-important and was achieved by means of the Lysholm headband and a plastic-foam cushion.
In only a few cases was sedation found necessary before the scan.
A basic principle in all radiological examinations is to take two or more projections at right angles wherever possible. Only by this means can a lesion be satisfactorily defined and located.
The scanning detector is so designed that it is focused 6.5 cm. from its surface. For this reason the clinically indicated lateral scan was always done first, as this aspect covers a greater volume of brain tissue than either the prone or supine view. The second projection is determined by the position of the mass as seen on the lateral view. Thus if the lesion lies anteriorly a supine scan is indicated and if posteriorly a prone scan. 203Hg chlormerodrin has a physical half-life of 48 days and an estimated biological half-life of 13 hours. This combination results in a renal radiation dose which has been variously estimated at 50 to 60 rads. For this reason no patient was scanned more than once with this substance. When follow-up scans were indicated they were undertaken after a suitable interval with an isotope giving less radiation to the kidneys.
In the last 30 of these first 100 cases a modification was made in the presentation of the results. This consisted of superimposing an underexposed x-ray film on the same scan by t double-exposure technique described by Marryat and Bull (1964) (Special Plate, Figs. 1 and 2). It was found that this, while in no way altering the scan, made the lesion easier to locate accurately. It has proved to be of great value, particularly in positioning biopsy burr-holes and craniotomy boneflaps.
Interpretation of the Scan
As in all other radiographic procedures, this requires experience, and the first step is to become thoroughly familiar with the appearances of the normal. There are certain areas of the brain scan which always appear relatively darker than others. The higher the uptake of isotope the greater the darkening of the film. These normal dark areas are: (1) a ring or "halo" shadow in the lateral view within the periphery of the skull vault, probably due to the activity of the blood in the sagittal sinus and in that part of the scalp tangential to the scan; (2) dark areas over the paranasal and mastoid air-cells; and (3) a dark zone over the suboccipital muscle groups. Thus for a peripheral shadow to be regarded as pathological it must be perceptibly-darker than the rest of the halo, whereas a slight increase in darkening in the usually relatively " empty " space centrally must arouse suspicion, even though this may be no darker than the halo itself (Special Plate, Figs. 1 and 2) .
Results
An analysis of the first 100 cases has been made ( Table I) . Some of the negative and equivocal cases were scanned a second time after a few months, when the clinical suspicion of a tumour remained strong; three further positives were thus detected (Table I) . Sometimes the scan examination was undertaken at a point in time before the pathological process was sufficiently florid to be detectable. and malignant astrocytoma. The patient, a man aged 55, died within a fortnight at another hospital.
Case 5 showed bifrontal masses with an isthmus joining them. Added experience soon showed that this was pathognomonir of a corpus-callosum astrocytoma (see below). Further con,-firmation was provided by air encephalography, which showed a deformity of the anterior horns of both lateral ventricles. This patient also died within a fortnight, but necropsy was refused. Case 4 was submitted to carotid angiography, when many pathological vessels were shown in a region where the scan was positive. These vessels were characteristic of, a rapidly growing
Metastases
The scan was positive in 11 cases where metastases were suspected (Table IV) . Nine of the 11 were known to have primary carcinomas of the bronchus and one had had a carcinoma of the breast removed four years previously. In the remaining case the primary site was unknown ; the histological description at biopsy was " papillary-columnar carcinoma."
Scanning showed three masses in the brain in two cases, two in three cases, and solitary masses in the remaining six. Necropsy was performed in only one case (No. 31); the three metastases shown on scanning were all confirmed.
A twelfth case (No. 90,  
Meningiomas
Eight meningiomas were revealed by scanning. Seven were new cases and the last (Case 41) had a recurrent tumour. The tumours were situated in the following positions: (1) frontal pole, bilateral involving falx:; (2) left subfrontal, supraorbital; (3) convexity (three cases) ; (4) sphenoidal ridge; (5) parietal parasagittal, involving falx (recurrent tumour). All were removed surgically and confirmed histologically, except for the recurrent tumour, where the diagnosis was hardly in doubt.
Miscellaneous Positives
There were nine cases in this group (Table V) . Four masses of confirmed different pathology were revealed-a meningosarcoma, an extradural haematoma, a large aneurysm (4.7 by 3.5 cm.), and an abscess. 
Equivocal Scans
In six of the 100 scans (Cases 95-100) a suspi observed on the scan, but the differentiation was positive diagnosis could not be made. )ion. Scanning raphy was also I to enter the cisterns, which tricles the possiIways has to be scan several months later, and biopsy showed the presence of a grade III astrocytoma.
There were 22 cases which were almost certainly truly negative (Table VII) . Case 90 had a positive scan a few months later but at the time of the initial scan there was good evidence that the cerebral metastases were quiescent, as has been indicated above.
Explanation of False Negatives il. in the lumbar
It has been shown by previous workers that masses of mer. At the last less diameter than about 2 cm. seldom register on the phototom-free and the scan. This could well explain some of the 17 false concluded that negatives listed in Table VI . Thus, for example, Case 52 had an orbital meningioma removed, the diameter of which was only 1.5 cm. Case 54 had a presumed metastasis in the orbit from a primary breast tumour ; there were multiple known metastases elsewhere in the body, and it icious zone was is quite likely that there was a tumour in the orbit of a diameter well be that at the time of the scan examination some three months previously it was less than 2 cm.
There was one colloid cyst of the paraphysis (Case 61). These isotope in suspected cysts probably never attain a diameter quite as great as 2 cm. One would therefore expect the scan to be negative even if such scan at the first cysts should take up the isotope, and it has not yet been shown sence of a leftthat they do.
False-negative scans resulting from small tumour-sizesometimes coupled with a deep situation (as in the case of midline tumours)-have been the subject of much study. As a result of this, equipment of much greater sensitivity and discrimination than is now available is being developed. When this comes into general use the number of false negatives due to small tumour-size should be very greatly reduced, though there will always, presumably, remain tumours too small for identification by any radiological means.
Other reasons than size must be sought for the failure of the scan in the remaining cases listed in Table VI . The experience of others has shown that pituitary tumours very seldom give a positive scan. It is also well known that astrocytomas of a low-grade malignancy very seldom give a positive scan. However, positive scans would have been expected in Case 51, a quite large right parietal meningioma, and in Cases 55 and 56, both grade III astrocytomas. But again it is also the experience of others that these tumours do not always take up the isotope.
It is said that posterior-fossa masses are difficult to demonstrate by scanning on account of the high take-up both by the mastoid cells and by the suboccipital muscles, which potentially mask any underlying lesion. In the first 100 cases there were only two positives in the posterior fossa-a metastasis and a meningosarcoma. The latter lay in the cerebello-pontine angle and simulated an acoustic neuroma clinically. There were no false-negative posterior-fossa scans.
Mode of Uptake of Isotope
The means by which tumours and other lesions such as abscesses, haematomas, and cysts selectively absorb isotopes is Millikan and Sayre (1964) . The patient was a 70-year-old woman with a five-months history rather suggestive of a mass in the left hemisphere. Two days before death 500 juc. of radio-iodinated polyvinyl pyrrolidone was injected intravenously. A brain scan was scheduled 48 hours later, but the patient died in the meantime. However, the pathologist sent the exposed brain for scanning. A high take-up of isotope was recorded in the posterior parietal region. Subsequently, radioactivity was estimated quantitatively in the various parts of the brain. The count per gramme of tumour, which was a grade IV astrocytoma, was 271 times that of normal brain. Most cerebral metastases are derived from the bronchus (Table IV) , as were 9 of the 11 cases in the present series. If the primary lesion is detected and only one mass is seen in the brain scan, a presumptive diagnosis can be made. However, the primary lesion is often not demonstrable, and then the diagnosis can be made with any confidence only if multiple masses are demonstrated. In this series more than one mass was shown in 5 out of 11 cases (Table IV) . One has the Isotope Encephalography-Bull and Marryat BRITISH Isotope~~~b MEDICAL JOURNAL impression that multiple metastases are more readily shown by scanning than by pneumography or angiography. Single metastases are often revealed by these latter methods, but second or third ones are not often shown.
While it is possible to predict the pathology of a certain number of lesions by studying the topography, this is by no means always so. Planiol (1963) uses an entirely different technique by means of which she is able to make a specific diagnosis in a much higher percentage of cases. Her method depends upon the change in count rate at fixed points on the skull at intervals of 2, 24, and 48 hours after an intravenous injection of radioiodinated human serum albumin. She has shown that meningiomas take up the isotope early and metastases late, while the astrocytomas take it up at an intermediate point in time. Since Planiol's method is based purely on count figures, there is no topographical representation of the tumours. Thus it is not possible by her technique to demonstrate, for example, an astrocytoma invading the corpus callosum. However, in her series she was able to diagnose correctly 92% (175 out of 190) meningiomas, 93% (292 out of 315) glioblastomas, 56% (48 out of 85) astrocytomas (corresponding to our grade I and grade II astrocytomas), and 90% (216 out of 240) metastases.
The most reliable diagnosis of all in her series was related to abscess, where the accuracy was 100% (18 out of 18). In our single case the abscess was certainly very clearly defined (Case 46).
It would seem that the best exploitation of the injected isotope would be derived from a combination of photoscanning with Planiol's technique. It is our intention to pursue this in the near future.
Summary
The results of 100 brain scans are described. All the scans were made with 203Hg chlormerodrin using a standard technique. There was no selection of cases referred by neurologists and neurosurgeons, except that patients under the age of 18 were excluded.
There were 53 positive scans, and all these patients appeared to have lesions, though not all these were confirmed histologically. There were 42 negative scans. Of these, 22 were probably truly negative. The remaining 20 were proved to be false-that is, these patients harboured tumours not demonstrated by the method. The causes of the false negatives are discussed and their reduced number in the future is foreshadowed.
There were five equivocal scans. These showed some departure from the normal, but the appearances were not sufficiently clear-cut for definite diagnosis.
Since a positive scan always denotes a lesion and the scanning process is painless and free from risk, it seems that, ideally, this investigation should be made before angiography and/or pneumography. But a negative scan in the face of positive clinical evidence of a mass always requires further investigation.
The method is particularly valuable in the investigation of out-patients and of patients whose clinical picture hardly justifies submission to the more traumatic procedures which also carry some morbidity.
Scanning has been a great help in the diagnosis of metastases, because the older-established neuroradiological procedures tend to show only the larger ones. The results in these cases suggest that secondary deposits in the brain are more often multiple than was previously suggested by classical neuroradiological investigation, although well known by pathologists.
Location of brain turnours by modern scanning techniques is accurate. In some cases the contour and topography allow a precise pathological diagnosis to be made. Unfortunately this is by no means always so, but it is hoped that still greater accuracy will be achieved by refining the technique.
Isotope encephalography has clearly earned its place alongside other neuroradiological contrast methods of investigation.
The application of newer methods to the detection of vitamin B12 and folic-acid deficiencies has clarified many problems in patients with megaloblastic anaemia, and we have a clearer understanding of these problems than was the case 10 years ago. The situation is less satisfactory, however, in megaloblastic anaemia in pregnancy. Diagnostic criteria are uncertain and the apparent incidence varies in different hospitals, from being so low that the condition is regarded as a rarity (Clark, 1952) to being so common that it is diagnosed in 1 in 25 of all pregnant subjects (Hourihane, Coyle, and Drury, 1960) . Divergent views have been expressed about the value of the newer tests for folic-acid deficiency (Chanarin, Rothman, and Watson-Williams, 1963 ; Hibbard and Hibbard, 1963 ; Ball and Giles, 1964 ; Hansen, 1964) , and there is disagreement both about the wisdom of folic-acid supplements in pregnancy (Varadi, 1964; Forshaw, Moorhouse, and Harwood, 1964) and about how large this supplement should be. The purpose of this paper is to report some of the results of a clinical trial in pregnancy wherein normal pregnant women
